Trial NCT00052715

View at ClinicalTrials.gov 
Org. Study IDs: NABTC-0105
Secondary IDs: CDR0000258685 NCI-2012-02506

Last trial update was posted on 2018-07-18

MeSH Interventions

Poly ICLC

MeSH Conditions

Central Nervous System Neoplasms Glioblastoma Nervous System Neoplasms

Other Conditions

Brain and Central Nervous System Tumors

Stopping Reasons

prematurely discontinued after results of the EORTC phase-3 study defined the SOC for newly diagnosed GMB pts as RT plus concomitant and adjuvant TMZ

Limitations And Caveats

Enrollment was prematurely discontinued after the results of the EORTC phase-3 study defined the standard of care for newly diagnosed glioblastoma patients as radiotherapy plus concomitant and adjuvant temozolomide (2005)

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID